fashion -WSS

fashion

author：comprehensive 2025-10-02 22:58:19 - browse：877

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Readout Newsletter: Amylyx, Aurinia, and IQVIA

focus

WSS

Why don't Americans have at

Sanofi strikes deal with Novavax, boosting the vaccine maker

Study gives hint on South Asians’ higher risk of cardiovascular disease

Juul documents reveal insider tactics on political lobbying

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Juul documents reveal insider tactics on political lobbying

hotspot

fashion

The need-to-know this morning

Is it time to worry about Moderna?

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Affirmative action in medical school literally saved lives

Study: Adult vaccinations pay for themselves in societal benefits

Tori Bowie and the unacceptable rates of Black maternal death

Having children helps parents live longer, especially after age 80

Wildfire smoke exposes gaps in outdoor worker protections

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Cancer drug shortages should be causing more outrage

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

focus

Medicare says breakthrough device reimbursement rule to come by summer

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Study: Adult vaccinations pay for themselves in societal benefits

Study: Adult vaccinations pay for themselves in societal benefits

Abbott's new heart device gets FDA advisory panel nod

CDC wastewater surveillance dashboard to track bird flu hotspots

explore

focus

Wikipedia

focus